Applied Methods of Cost-effectiveness Analysis in Healthcare
OUP Oxford, 2011 - Business & Economics - 313 pages
The third volume in the Handbooks in Health Economic Evaluation series, this book provides the reader with a comprehensive set of instructions and examples of how to perform an economic evaluation of a health intervention. It focuses solely on cost-effectiveness analysis in health care. The book is developed out of the Advanced Methods of Cost-Effectiveness Analysis course taught at the University of Oxford and the four main sections mirror the four principal components of the course: Outcomes, Costs, Modelling using decision tress and Markov models, and Presenting cost-effectiveness results.&L ABOUT THE SERIES Series editors Alastair Gray and Andrew Briggs Economic evaluation of health intervention is a growing specialist field, and this series of practical handbooks tackles, in depth, topics superficially addressed in more general economics books. Each volume includes illustrative material, case histories and worked examples to encourage the reader to apply the methods discussed, with supporting material provided online. The series is for health economists in academia, the pharmaceutical industry and the health sector, those on advanced health economics courses, and health researchers in associated fields.
What people are saying - Write a review
We haven't found any reviews in the usual places.
2 Economic evaluation in health care
3 Life tables and extrapolation
4 Modelling outcomes using patientlevel data
5 Measuring valuing and analysing health outcomes
6 Defining measuring and valuing costs
7 Analysing costs
Other editions - View all
acceptability curve alternative approach assumption average benefits bootstrap bootstrap replicates breast cancer Briggs calculate ceiling ratio cell censored Chapter clinical trials cohort column confidence intervals considered control group cost and effect cost data cost-effectiveness analysis cost-effectiveness plane cost-minimization analysis costs and outcomes covariance dataset Dead death decision analytic model decision models decision tree diabetes discount disease distribution drug economic evaluation effect differences estimate example exercise expectancy extrapolation Figure follow-up hazard hazard ratios Health Economics health gain health-care ICER incremental cost incremental cost-effectiveness ratio individual intervention Journal KMSA life-table life-year gained Markov model mean cost measure metformin methods mortality option parameter patient-level patients period Pharmacoeconomics population QALY QALY gained quality-adjusted Recurrence resource risk sample screening Sculpher sensitivity analysis standard error standard gamble Statistics survival analysis survivor function Table therapy tion transition probabilities treatment group TreeAge uncertainty unit costs valuation variable worksheet